Walleye Capital’s Zepp Health ZEPP Stock Holding History

Walleye Capital’s Portfolio ZEPP Stock Details ZEPP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-4,926	Closed	-$259K	–	1020
2020 Q1	$259K	Buy	+4,926	New	+$267K	0.06%	376

Other funds holding ZEPP

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Walleye Capital's ZEPP Position: Q2 2020 in Review

Walleye Capital sold out of Zepp Health (ZEPP) in Q2 2020, closing a stake of 4,926 shares — an estimated $259K sold.

Walleye Capital first reported a position in ZEPP in Q1 2020 and held it in 1 quarter. The position peaked at $259K in Q1 2020. 61 funds tracked by Wall St. Rank hold ZEPP as of Q2 2020.

Walleye Capital reported no remaining Zepp Health position as of Q2 2020 after selling out during the quarter.
Walleye Capital sold 4,926 Zepp Health shares in Q2 2020, an estimated $259K.
Walleye Capital first reported a position in Zepp Health in Q1 2020 and held it in 1 quarter.
Walleye Capital's Zepp Health position peaked at $259K in Q1 2020.
61 funds tracked by Wall St. Rank held Zepp Health as of Q2 2020.

Based on Walleye Capital's 13F filing for Q2 2020, filed 14 Aug 2020.